The Sallandsche Specialisten Coöperatie, the investment vehicle of the VSD (a partnership of medical specialists affiliated to the Deventer Hospital) provided growth capital to the medical start-up Ventinova and thereby acquired a small minority in the share capital of Ventinova.
Lindenaar & Co acted as financial advisor to the Sallandsche Specialisten Coöperatie. The activities consisted amongst others of reviewing the business plan and financial projections and reviewing the share purchase agreement and shareholders agreement.
Profile the Sallandsche Specialisten Coöperatie
The Sallandsche Specialisten Coöperatie was recently founded by members of the VSD. The Sallandsche Specialisten Coöperatie aims to provide growth capital to promising start-ups that contribute to advances in care and is the first of its kind in the Netherlands. The VSD consists of more than 100 medical specialists, working at the Deventer Hospital. The Deventer Hospital is a medium-sized hospital (€177 million revenue in 2014) providing basic and specialised healthcare for the inhabitants of the region Salland. The hospital is one of the top general hospitals in the Netherlands.
Profile Ventinova
Ventinova, founded in 2013, develops and sells innovative medical devices in the field of airway management and patient ventilation. Ventinova developed the patented expiratory ventilation assistance technology, better known as EVA®. Current products Ventrain® and Cricath® are sold in over 20 countries. Thereby, the EVA® technology has already entered many hospitals. Now to be followed by the EVA® device and the CNB tube.